HOME
ABOUT IAC
CONTACT
A-Z INDEX
DONATE
SHOP
SUBSCRIBE
Immunization Action Coalition

Advisory Committee on Immunization Practices

FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ACIP Recommendations: Chronological

View Alphabetical Index by Vaccine View 2011 through present View 1991 through 2010
 

Recommendations - 2020

Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, September 25, 2020, Volume 69(9); 1–41
HTML  |  PDF
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2020–21 Influenza Season
Source: MMWR, August 21, 2020, 69 (8); 1–24
HTML  |  PDF
Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, July 3, 2020, Vol 69 (5);1-38
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2020
Source: MMWR, February 7, 2020, 69 (5);130-132
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2020
Source: MMWR, February 7, 2020, 69 (5);133-135
HTML  |  PDF
Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
Source: MMWR, February 7, 2020, 69 (5);136-139
HTML  |  PDF
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, January 24, 2020, Vol 69 (3);77-83
HTML  |  PDF
 

Recommendations - 2019

Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019
Source: MMWR, December 13, 2019, 68(4);1–14
HTML  |  PDF
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged 65 Years and older: Updated Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, November 22, 2019; 68(46):10691075
HTML  |  PDF
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2019–20 Influenza Season
Source: MMWR, August 23, 2019, 68(3); 1–21
HTML  |  PDF
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR August 16, 2019; 68(32): 698702
HTML  |  PDF
Interim Infection Prevention and Control Recommendations for Measles in Healthcare Settings
Source: CDC Infection Control Guideline Library
Updated July 2019
(Not an ACIP statement but an important document from CDC.)
HTML  |  PDF
Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, July 19, 2019, 68(2); 1-33
HTML  |  PDF
Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness
Source: MMWR, February 15, 2019; 68(6);153–156
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2019
Source: MMWR, February 8, 2019, 68 (5);112–114
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2019
Source: MMWR, February 8, 2019, 68 (5);115–118
HTML  |  PDF
 

Recommendations - 2018

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2018–19 Influenza Season
Source: MMWR, August 24, 2018, 67(3); 1-20
HTML  |  PDF
Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
Source: MMWR, June 8, 2018; 67 (22); 643–645
HTML  |  PDF
Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, April 27, 2018; 67 (2):1-44
HTML  |  PDF
Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant
Source: MMWR, April 20, 2018; 67 (15): 455-458
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger United States, 2018
Source: MMWR, February 6, 2018; 67
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger United States, 2018
Source: MMWR, February 6, 2018; 67
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2018
Source: MMWR, February 6, 2018; 67
HTML  |  PDF
Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
Source: MMWR, January 26, 2018; 67(3); 103–108
HTML  |  PDF
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, January 12, 2018; 67(1); 1–31
HTML  |  PDF
Recommendations of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak
Source: MMWR, January 12, 2018; 67(1); 33–37
HTML  |  PDF
 

Recommendations - 2017

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season
Source: MMWR, August 25, 2017, 66(2); 1–20
HTML  |  PDF
Updated Recommendations for Use of MenB-FHbp Serogroup B (Trumenba) Meningococcal Vaccine
Source: MMWR, May 19, 2017; 66(19); 509-513
HTML  |  PDF
Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine
Source: MMWR, May 12, 2017; 66 (18); 482-485
HTML  |  PDF
General Best Practice Guidelines for Immunization: Best Practices Guidance of the Advisory Committee on Immunization Practices
Source: CDC website 4/20/17 (this is the original publication date - guidelines are updated by CDC as needed)
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger United States, 2017
Source: MMWR, February 10, 2017; 66 (5); 134-135
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older United States, 2017
Source: MMWR, February 10, 2017; 66 (5); 136-138
HTML  |  PDF
Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States
Source: MMWR, January 13, 2017; 66(01); 23–25
(Not an ACIP statement but an important document from CDC.)
HTML  |  PDF
 

Recommendations - 2016

Use of a 2-Dose Schedule for Human Papillomavirus Vaccination -Updated Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, December 16, 2016; 65(49);1405-8
HTML  |  PDF
Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons Advisory Committee on Immunization Practices (ACIP), 2016
Source: MMWR, November 4, 2016, 65(43);11891194
HTML  |  PDF
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 201617 Influenza Season
Source: MMWR, August 26, 2016, 65(5):1-54
HTML  |  PDF
Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses—Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015
Source: MMWR, March 18, 2016, 65(10):257-262
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2016
Source: MMWR, February 2, 2016; 65(4):1-2
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2016
Source: MMWR, February 2, 2016; 65(4):1-3
HTML  |  PDF
 

Recommendations - 2015

Back to top
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015
Source: MMWR, October 23, 2015; 64(41)11711176
HTML  |  PDF
Update: Shortened Interval for Postvaccination Serologic Testing of Infants Born to Hepatitis B-Infected Mothers
Source: MMWR, October 9, 2015; 64(39):1118-20
(Not an ACIP statement but an important document from CDC.)
HTML  |  PDF
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, September 4, 2015; 64(34):944-947
HTML  |  PDF
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season
Source: MMWR, August 7, 2015; 64(30):818-825
HTML  |  PDF
Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015
Source: MMWR, June 19, 2015; 64(23);647-650
HTML  |  PDF
Use of Serogroup B Meningococcal Vaccines in Persons Aged >10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
Source: MMWR, June 12, 2015; 64(22);608-612
HTML  |  PDF
Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, March 27, 2015; 64(11):300-304
HTML  |  PDF
Updated Recommendations for the Use of Typhoid Vaccine — Advisory Committee on Immunization Practices, United States, 2015
Source: MMWR, March 27, 2015; 64(11):305-308
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2015
Source: MMWR, February 6, 2015; 64(04):93-94
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2015
Source: MMWR, February 6, 2015; 64(04):91-92
HTML  |  PDF
 

Recommendations - 2014

Back to top
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged >65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, September 19, 2014; 63(37):822-825
HTML  |  PDF
Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, August 29, 2014; 63(RR-5):1-30
HTML  |  PDF
Update on Recommendations for Use of Herpes Zoster Vaccine
Source: MMWR, August 22, 2014; 63(33):729-731
HTML  |  PDF
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2014–2015
Source: MMWR, August 15, 2014; 63(327):691–697
HTML  |  PDF
Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease
Source: MMWR, June 20, 2014; 63(24):527-530
HTML  |  PDF
Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Recommendations and Reports
Source: MMWR, February 28, 2014; 63(RR01):1-14
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2014
Source: MMWR, February 7, 2014; 63(05):108–109
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2014
Source: MMWR, February 7, 2014; 63(5):110–112
HTML  |  PDF
 

Recommendations - 2013

Back to top
CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management – Recommendations and Reports
Source: MMWR, December 20, 2013; 62(rr10);1-19
(Not an ACIP statement but an important document from CDC.)
HTML  |  PDF
Use of Japanese Encephalitis Vaccine in Children: Recommendations of the Advisory Committee on Immunization Practices, 2013
Source: MMWR, November 15, 2013; 62(45):898-900
HTML  |  PDF
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014
Source: MMWR, September 20, 2013; 62(RR–7):1-48
HTML  |  PDF
Updated Recommendations for Use of VariZIG -- United States, 2013
Source: MMWR, July 19, 2013; 62(28):574-6
HTML  |  PDF
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 28, 2013; 62(25):521-524
HTML  |  PDF
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 14, 2013; 62(RR04):1-34
HTML  |  PDF
Prevention and Control of Influenza with Vaccines: Interim Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013 Weekly
Source: MMWR, May 10, 2013; 62(18):356
HTML  |  PDF
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, March 22, 2013; 62(RR02):1-22
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, February 22, 2013;62(07):131-5
HTML  |  PDF
Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedules for Persons Aged 0 Through 18 years and Adults Aged 19 Years and Older — United States, 2013
Source: MMWR Supplements, February 1, 2013; 62(01):1-21
HTML  |  PDF
Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
Source: MMWR, January 25, 2013; 62(3):52-4
HTML  |  PDF
 

Recommendations - 2012

Back to top
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, October 12, 2012; 61(40):816-9
HTML  |  PDF
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2012–13 Influenza Season
Source: MMWR, August 18, 2012;61(32);613-8
HTML  |  PDF
Updated CDC Recommendations for the Management of Hepatitis B Virus–Infected Health-Care Providers and Students
(Not an ACIP statement but an important document from CDC.)
Source: MMWR, July 6, 2012; 61(RR03):1-12
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70
HTML  |  PDF
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Source: MMWR, June 1, 2012; 61(21):394-5
HTML  |  PDF
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years - United States, 2012
Source: MMWR, February 10, 2012; 61(5):1-4
HTML  |  PDF (pages 31–34)
Recommended Adult Immunization Schedule — United States, 2012
Source: MMWR, February 3, 2012; 61(4):1-7
HTML  |  PDF (pages 36–43)
 

Recommendations - 2011

Back to top
Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, December 23, 2011; 60(50):1709-11
HTML  |  PDF
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8
HTML  |  PDF
 
Immunization of Health-Care Personnel: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, November 25, 2011; 60(RR07):1-45
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months -- Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426
HTML  |  PDF
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, October 14, 2011; 60(40):1391-2
HTML  |  PDF
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 26, 2011; 60(33):1128-1132
HTML  |  PDF
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011; 60(30):1018-1019
HTML  |  PDF
Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine -- Advisory Committee on Immunization Practices, 2011
Source: MMWR, May 27, 2011; 60(20):661-3
HTML  |  PDF
Update on Japanese Encephalitis Vaccine for Children
Source: MMWR, May 27, 2011; 60(20):664-5
HTML  |  PDF
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years -- United States, 2011
Source: MMWR, February 11, 2011; 60(5):1-4
HTML  |  PDF (pages 29–32)
Recommended Adult Immunization Schedule --- United States, 2011
Source: MMWR, February 4, 2011; 60(04):1-4
HTML  |  PDF (pages 41–44)
General Recommendations on Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60
HTML  |  PDF
Updated Recommendations for Use of Meningococcal Conjugate Vaccines--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, January 28, 2011; 60(03):72-76
HTML  |  PDF
 
Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza
Source: MMWR, January 21, 2011; 60(RR01):1-24
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
 
For ACIP recommendations published earlier, visit this page.
This page was updated on September 24, 2020.
This page was reviewed on April 27, 2018.
 
- Guide to immunize.org -
A-Z INDEX
ABOUT IAC
IAC in the News
Staff
IAC History through Film
ACIP
RECOMMENDATIONS
ADOLESCENT VACCINATION
ADULT VACCINATION
ADULT VACCINATION GUIDE
ASK THE EXPERTS
Administering Vaccines
COVID-19 & Routine Vac
Hepatitis B
MMR
Storage and Handling
>> view all
BECKY PAYNE AWARD
BILLING & CODING
BIRTH DOSE GUIDEBOOK
CALENDAR OF EVENTS
CDC INFORMATION
CDC SCHEDULES
CLINIC TOOLS
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Screening for Contraindications
Vaccination and COVID-19
Vaccine Recommendations
Vaccine Storage & Handling
>> view all
COALITIONS FOR
IMMUNIZATION
CONTRIBUTE TO IAC
COVID-19 RELATED
Ask the Experts: COVID-19
   & Routine Vac
Clinic Tools: Vaccination and
   COVID-19
Repository of Resources
DEAR COLLEAGUE LETTERS
16-year-old Visit
HPV
MenACWY Dose #2
DONATE TO IAC
EDUCATIONAL MATERIALS
EMAIL NEWS SERVICES
E-NEWSLETTER: IAC EXPRESS
EXEMPTIONS
FAQs
FAVORITES
FDA PACKAGE INSERTS
FILMS ABOUT IAC
GIVE BIRTH TO THE
END OF HEP B
HANDOUTS FOR
PATIENTS & STAFF
View All Materials
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Contraindications / Precautions
Documenting Vaccination
Healthcare Personnel
Managing Vaccine Reactions
Parent Handouts
Pregnancy and Vaccines
Q&As: Diseases and Vaccines
Q&As: Easy-to-Read
Schedules for Patients
Screening Checklists
Standing Orders Templates
Storage & Handling
Strategies & Policies
Temperature Logs
Top Handouts
Vaccine Confidence
Vaccine Recommendations
>> view all
HEP B BIRTH DOSE
HONOR ROLLS
Hep B Birth Dose
Mandatory Flu Vaccination for HCP
MenB Vaccination for Colleges
IAC EXPRESS
Subscribe to IAC Express
IMAGE LIBRARY
LAWS AND MANDATES
MANUFACTURERS
MASS VACCINATION
RESOURCES
NATIONAL ADULT &
INFLUENZA
IMMUNIZATION SUMMIT
NEWS & INFORMATION
NEWSLETTER SIGN UP
OFFICIAL RELEASES
ACIP
CDC
FDA
PACKAGE INSERTS
PARTNERS
PHARMACISTS
PHOTOS
POWERPOINT SLIDE SETS
PREGNANCY AND
VACCINES
PRESS ROOM
PROTECT NEWBORNS
FROM HEP B
PUBLICATIONS
IAC Express
Vaccinating Adults:
   A Step-by-Step Guide
Hepatitis B What Hospitals
   Need to Do to
   Protect Newborns
Needle Tips Archive
Vaccinate Adults Archive
Vaccinate Women Archive
REGISTRIES
SCHOOL VACCINATION REQUIREMENTS
SHOP IAC
DVD Immunization Techniques
Laminated Schedules
Patient Record Cards
Flu Vaccine Buttons and Stickers
"Vaccines Save Lives" Pins
SITE MAP
SLIDE SETS
STANDING ORDERS
STATE INFORMATION
Immunization Websites
Laws and Mandates for School Entry
Immunization Program Managers
SUBSCRIBE TO IAC EXPRESS
SUPPORT IAC
TALKING ABOUT VACCINES
Adjuvants & Ingredients
Autism
Importance of Vaccination
MMR Vaccine
Religious Concerns
Vaccine Safety
>> view all
TECHNICALLY SPEAKING
TRANSLATIONS
IAC Handouts
VISs
TRAVEL (INTERNATIONAL)
UNPROTECTED PEOPLE
STORIES
Chickenpox
Hepatitis B
Measles
Whooping Cough
>> view all
VACCINATING ADULTS:
A STEP-BY-STEP GUIDE
VACCINE INFORMATION
STATEMENTS
Translations
VACCINE
MANUFACTURERS
VACCINE POLICY &
LICENSURE
ACIP
FDA
WHO
VACCINE SAFETY
VACCINE TIMELINE
VACCINES
Hepatitis B
HPV (Human papillomavirus)
Influenza
Pertussis
Varicella
>> view all
VIDEO OF THE WEEK
VIDEO LIBRARY
VISs
Translations
WHAT'S NEW OR UPDATED AT IAC
Handouts
VISs and Translations
Web Pages
 
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
 
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 6NH23IP22550) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.